- Home
- CANF vs GVH Comparison
CANF vs GVH Comparison
Compare CANF & GVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CANF | GVH |
|---|---|---|
| Founded | 1994 | 2016 |
| Country | Israel | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5M | 2.9M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | CANF | GVH |
|---|---|---|
| Price | $4.23 | $1.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $9,750.00 | $80.00 |
| AVG Volume (30 Days) | 555.6K | ★ 1.2M |
| Earning Date | 02-03-2026 | 02-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 11.95 |
| Revenue | $560,000.00 | ★ $21,878,867.00 |
| Revenue This Year | $461.72 | $141,706.20 |
| Revenue Next Year | N/A | $3.35 |
| P/E Ratio | ★ N/A | $0.10 |
| Revenue Growth | N/A | ★ 24.52 |
| 52 Week Low | $3.36 | $1.20 |
| 52 Week High | $46.60 | $364.00 |
Technical Indicators
Market Signals| Indicator | CANF | GVH |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 30.62 |
| Support Level | N/A | $1.32 |
| Resistance Level | N/A | $1.47 |
| Average True Range (ATR) | 0.00 | 0.45 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 0.00 | 3.94 |
Price Performance
Historical ComparisonAbout CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.
About GVH Globavend Holdings Limited
Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.